Hepatitis C Statistics
1 pages | Janvier 2006 |
This Database Table is a one-page table of hard-to-find numerical information.
The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif |
80,00 €
|
| |
| |
Countries with the Highest Prevalence of HIV/AIDS
1 pages | Janvier 2006 |
This Database Table is a one-page table of hard-to-find numerical information.
The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif |
80,00 €
|
| |
| |
Stakeholder Insight: Hepatitis in China - Liver Let Die?
310 pages | Décembre 2005 |
IntroductionHepatitis is a major health problem in China, which is home to one third of hepatitis B patients and one quarter of hepatitis C patients globally.
HBV vaccination, together with HBV and |
12 920,00 €
|
| |
| |
Commercial Insight: Herpes and Respiratory Antivirals - Leaders Rise and Fall
218 pages | Octobre 2005 |
IntroductionWithin the herpes and respiratory antiviral subcategory HSV/VZV products have been key growth drivers, accounting for 77% of a market worth $2,190m in 2004.
Despite lost of US branded V |
9 690,00 €
|
| |
| |
Pipeline Insight: Hepatitis B - New Kids on the Block
211 pages | Avril 2005 |
IntroductionAccording to the WHO, 350-400 million people are chronically infected with HBV progresses to liver cirrhosis and hepatocellular carcinoma.
Previously HBV has been treated with lamivudin |
9 120,00 €
|
| |
| |
Stakeholder Insight: Hepatitis B & C - Winning Battles But Not The War
329 pages | Décembre 2004 |
IntroductionAccording to the WHO, 350400 million are chronically infected with HBV and 170200 million with HCV.
Although HBV vaccination and routine screening of donated blood has decreased inciden |
12 160,00 €
|
| |
| |
The Antivirals Market Outlook: Market analysis of future growth and leading players by sector
178 pages | Janvier 2005 |
Business Insights have teamed up with IMS Health to bring you, ‘The Antivirals Market Outlook: Market analysis of future growth and leading players by sector.’ This unique product offering provides an |
2 443,75 €
|
| |
| |
Recommendations for Diagnostic Testing for Hepatitis C
1 pages | Janvier 2006 |
This Database Table is a one-page table of hard-to-find numerical information.
The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif |
80,00 €
|
| |
| |
Commercial Perspectives: HIV - Benchmarking Rapid Antiretroviral Uptake
181 pages | Février 2005 |
IntroductionHistorically, HIV antiretrovirals have differed markedly in their speed of market uptake.
Now, to win market share in an already mature market, newly launched products need not only a s |
9 120,00 €
|
| |
| |
Approved AIDS and AIDS-Related Drugs, 1987-2003
1 pages | Janvier 2006 |
This Database Table is a one-page table of hard-to-find numerical information.
The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif |
80,00 €
|
| |
| |
